The drugmaker launched a campaign supporting its weight loss medication Contrave, all backed by a cover version of Lesley Gore’s 1963 hit “You Don’t Own Me.” ...

The campaign inspires individuals to seek help in taking control of their weight-loss efforts with CONTRAVE, an established ...

Naltrexone, a drug used to treat opioid and alcohol use disorder, was associated with just a 14% reduction in the risk of ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

but recent pharmaceutical advances have led to the development of weight loss drugs. These are based on natural hormones from the intestine that help control food intake, such as GLP and GIP.

Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...

The Food and Drug Administration has reaffirmed its decision that the shortage of tirzepatide, the active ingredient in the popular diabetes and weight loss drugs Mounjaro and Zepbound, is over. The ...

Further studies should include broader populations and head-to-head comparisons of bupropion/naltrexone with other active weight-loss agents ... of the two component drugs will require careful ...

While the drugs were developed to treat Type 2 diabetes, they have gained infamy for their dramatic weight loss effects (in the States, the FDA has approved them to help tackle obesity).

Novo Nordisk executives set a high bar for itself when it projected CagriSema could achieve 25% weight loss. When the GLP-1 combo didn’t hit that mark, investors reeled. Novo Nordisk’s executives ...

The breakthrough of weight loss jabs ‘opens the possibility of an end to the obesity pandemic’, says the World Health Organization (WHO) – but risks still need to be considered. The global health ...

Weight loss medications typically suppress a person ... Contrave belongs to a class of drugs known as bupropion/naltrexone. Bupropion is a type of antidepressant, whereas naltrexone is an ...